Vanberra Signal

NeuroFieldz

Curated by Signal

Brain monitoring technology

Overview

NeuroFieldz is commercializing Electric Field Encephalography (EFEG) technology, developed at the Northwestern University. The EFEG technology is a novel modality of monitoring brain activity using the electric fields of the brain (as opposed to electroencephalography, that measures the electric potentials at the scalp). EFEG is local and reference-less enabling miniaturization and portability. The company is developing EFEG sensors, called NeuroDots for continuous, wireless neuromonitoring with potential applications in the diagnosis and assessment of traumatic brain injury, cognitive performance assessment and enhancement for soldiers, design and development of human-machine and brain-computer interfaces, speech processing, and visual signal processing. The EFEG technology is patent protected and extensively validated.

Key facts

Founded
2012

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of FDA-approved patent-pending devices for the treatment of cardiac health

    Life Sciences TechnologyMinneapolis, United States
  • Developer of treatments for rare orphan conditions

    Life Sciences TechnologyGuilford, United States
  • Provider of AI interfaced protein synthesis therapies through automation and computation

    Life Sciences TechnologyUnited States

About NeuroFieldz

What does NeuroFieldz do?

NeuroFieldz is commercializing Electric Field Encephalography (EFEG) technology, developed at the Northwestern University.

Where is NeuroFieldz headquartered?

NeuroFieldz is headquartered in Newton, United States.

When was NeuroFieldz founded?

NeuroFieldz was founded in 2012.

Which sector is NeuroFieldz in?

NeuroFieldz operates in Life Sciences Technology.

Who are NeuroFieldz's competitors?

Companies similar to NeuroFieldz include CoraVie, OrphAI Therapeutics, and Celine Therapeutics.